Do community-based active case-finding interventions have indirect impacts on wider TB case detection and determinants of subsequent TB testing behaviour? A systematic review.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2021
Historique:
received: 23 06 2021
accepted: 15 11 2021
entrez: 24 3 2023
pubmed: 8 12 2021
medline: 8 12 2021
Statut: epublish

Résumé

Community-based active case-finding (ACF) may have important impacts on routine TB case-detection and subsequent patient-initiated diagnosis pathways, contributing "indirectly" to infectious diseases prevention and care. We investigated the impact of ACF beyond directly diagnosed patients for TB, using routine case-notification rate (CNR) ratios as a measure of indirect effect. We systematically searched for publications 01-Jan-1980 to 13-Apr-2020 reporting on community-based ACF interventions compared to a comparison group, together with review of linked manuscripts reporting knowledge, attitudes, and practices (KAP) outcomes or qualitative data on TB testing behaviour. We calculated CNR ratios of routine case-notifications (i.e. excluding cases identified directly through ACF) and compared proxy behavioural outcomes for both ACF and comparator communities. Full text manuscripts from 988 of 23,883 abstracts were screened for inclusion; 36 were eligible. Of these, 12 reported routine notification rates separately from ACF intervention-attributed rates, and one reported any proxy behavioural outcomes. Two further studies were identified from screening 1121 abstracts for linked KAP/qualitative manuscripts. 8/12 case-notification studies were considered at critical or serious risk of bias. 8/11 non-randomised studies reported bacteriologically-confirmed CNR ratios between 0.47 (95% CI:0.41-0.53) and 0.96 (95% CI:0.94-0.97), with 7/11 reporting all-form CNR ratios between 0.96 (95% CI:0.88-1.05) and 1.09 (95% CI:1.02-1.16). One high-quality randomised-controlled trial reported a ratio of 1.14 (95% CI 0.91-1.43). KAP/qualitative manuscripts provided insufficient evidence to establish the impact of ACF on subsequent TB testing behaviour. ACF interventions with routine CNR ratios >1 suggest an indirect effect on wider TB case-detection, potentially due to impact on subsequent TB testing behaviour through follow-up after a negative ACF test or increased TB knowledge. However, data on this type of impact are rarely collected. Evaluation of routine case-notification, testing and proxy behavioural outcomes in intervention and comparator communities should be included as standard methodology in future ACF campaign study designs.

Identifiants

pubmed: 36962123
doi: 10.1371/journal.pgph.0000088
pii: PGPH-D-21-00221
pmc: PMC10021508
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0000088

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Wellcome Trust
ID : 200901/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206575/Z/17/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N020618/1
Pays : United Kingdom

Informations de copyright

Copyright: © 2021 Feasey et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

I have read the journal’s policy and the authors of this manuscript have the following competing interests: JEG, HA, and ELC are authors of trials included in this systematic review. HA and ELC are members of the WHO TB Screening Guideline Development Group, which CM co-ordinates. JEG, HA, ELC, and PM have received research grants to their institutions for projects evaluating community-based active case-finding. All other authors declare no competing interests.

Références

J Am Geriatr Soc. 2007 Feb;55(2):277-83
pubmed: 17302667
Int J MCH AIDS. 2015;3(1):74-80
pubmed: 27621988
Int J Infect Dis. 2018 May;70:93-100
pubmed: 29476901
PLoS One. 2019 Feb 14;14(2):e0212035
pubmed: 30763378
BMC Public Health. 2016 Nov 11;16(1):1155
pubmed: 27835999
Implement Sci. 2017 Mar 9;12(1):33
pubmed: 28274245
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Lancet Public Health. 2021 May;6(5):e283-e299
pubmed: 33765456
BMJ Open. 2020 Sep 29;10(9):e037761
pubmed: 32994243
PLoS One. 2014 Mar 27;9(3):e92754
pubmed: 24675985
Cochrane Database Syst Rev. 2017 Nov 28;11:CD011432
pubmed: 29182800
PLoS One. 2015 Jul 29;10(7):e0130179
pubmed: 26222545
Int J Tuberc Lung Dis. 2014 May;18(5):509-14
pubmed: 24903784
PLoS One. 2016 Nov 29;11(11):e0165813
pubmed: 27898665
Public Health Action. 2015 Mar 21;5(1):70-3
pubmed: 26400604
Int J Tuberc Lung Dis. 2019 Jun 1;23(6):750-755
pubmed: 31315709
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
PLoS One. 2013 May 27;8(5):e63174
pubmed: 23723975
PLoS One. 2017 Mar 30;12(3):e0174692
pubmed: 28358877
BMJ Glob Health. 2017 Nov 02;2(4):e000390
pubmed: 29209537
Int J Tuberc Lung Dis. 2013 Apr;17(4):432-46
pubmed: 23485377
Lancet Glob Health. 2019 Apr;7(4):e482-e491
pubmed: 30824364
Nurse Educ. 2018 May/Jun;43(3):123-127
pubmed: 28817479
Int J Tuberc Lung Dis. 2014 Sep;18(9):1099-104
pubmed: 25189559
BMC Health Serv Res. 2018 Dec 14;18(1):965
pubmed: 30547793
PLoS One. 2014 Apr 10;9(4):e94465
pubmed: 24722399
Implement Sci. 2020 Nov 25;15(1):102
pubmed: 33239055
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Int J Tuberc Lung Dis. 2014 Sep;18(9):1105-7
pubmed: 25189560
Int J Tuberc Lung Dis. 2010 Jun;14(6):720-6
pubmed: 20487610
Indian J Tuberc. 2019 Oct;66(4):480-486
pubmed: 31813435
Front Psychol. 2018 Nov 06;9:2180
pubmed: 30459694
Int Health. 2014 Sep;6(3):181-8
pubmed: 25100402
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Am J Public Health. 2013 Jul;103(7):1292-300
pubmed: 23078465
Lancet. 2010 Oct 9;376(9748):1244-53
pubmed: 20923715
BMC Public Health. 2015 Feb 25;15:187
pubmed: 25885789
BMC Public Health. 2021 Jan 15;21(1):147
pubmed: 33451308

Auteurs

Helena R A Feasey (HRA)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
TB Centre, London School of Hygiene and Tropical Medicine, London, London.

Rachael M Burke (RM)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
TB Centre, London School of Hygiene and Tropical Medicine, London, London.

Marriott Nliwasa (M)

College of Medicine, University of Malawi, Blantyre, Malawi.

Lelia H Chaisson (LH)

Division of Infectious Diseases, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United States of America.

Jonathan E Golub (JE)

Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, MD, United States of America.

Fahd Naufal (F)

Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University, Baltimore, MD, United States of America.

Adrienne E Shapiro (AE)

Department of Global Health and Department of Medicine, University of Washington, Seattle, WA, United States of America.

Maria Ruperez (M)

TB Centre, London School of Hygiene and Tropical Medicine, London, London.

Lily Telisinghe (L)

TB Centre, London School of Hygiene and Tropical Medicine, London, London.
Zambart, University of Zambia School of Public Health, Ridgeway, Zambia.

Helen Ayles (H)

TB Centre, London School of Hygiene and Tropical Medicine, London, London.
Zambart, University of Zambia School of Public Health, Ridgeway, Zambia.

Cecily Miller (C)

WHO, Geneva, Switzerland.

Helen E D Burchett (HED)

Faculty of Public Health & Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Peter MacPherson (P)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
TB Centre, London School of Hygiene and Tropical Medicine, London, London.
Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

Elizabeth L Corbett (EL)

Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
TB Centre, London School of Hygiene and Tropical Medicine, London, London.

Classifications MeSH